⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22269 | 1.00 | — | — | |
| SCHEMBL6037582 | 1.00 | — | — | |
| SCHEMBL2184624 | 1.00 | — | — | |
| SCHEMBL19521748 | 1.00 | — | — | |
| SCHEMBL22270 | 1.00 | — | — | |
| SCHEMBL1355800 | 1.00 | — | — | |
| SCHEMBL31416087 | 1.00 | — | — | |
| SCHEMBL2184981 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL25230162 | 0.98 | CYP2D6 (0.56) | — | |
| Hydrochloric Acid SCHEMBL26120219 | 0.98 | CYP2D6 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11390662-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-07-19 | — | — | US | claimed |
| CN-104024272-B | Gene cluster for the biosynthesis of griselimycin and methyl griselimycin | 赛诺菲 | 2018-04-20 | — | — | CN | claimed |
| US-9758569-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-09-12 | — | — | US | claimed |
| EP-2766389-B1 | GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN | SANOFI SA (FR) | 2017-03-29 | — | — | EP | claimed |
| US-9422566-B2 | Gene cluster for biosynthesis of griselimycin and methylgriselimycin | SANOFI (FR) | 2016-08-23 | — | — | US | claimed |
| US-20140295457-A1 | GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN | SANOFI (FR) | 2014-10-02 | — | — | US | claimed |
| CN-104024272-A | Gene cluster for biosynthesis of griselimycin and methylgriselimycin | SANOFI SA | 2014-09-03 | — | — | CN | claimed |
| EP-2766389-A2 | GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN | SANOFI (FR) | 2014-08-20 | — | — | EP | claimed |
| EP-2586791-A1 | Gene cluster for biosynthesis of griselimycin and methylgriselimycin | SANOFI (FR) | 2013-05-01 | — | — | EP | claimed |
| WO-2013053857-A2 | GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN | SANOFI (FR) | 2013-04-18 | — | — | WO | claimed |
| WO-2007139914-A2 | COLLAGEN MIMICS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2007-12-06 | — | — | WO | claimed |
| US-20070275897-A1 | Collagen mimics | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-11-29 | — | — | US | claimed |
| US-20250059171-A1 | ANTIVIRAL COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2025-02-20 | — | — | US | disclosed |
| EP-4444711-A1 | ANTIVIRAL COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| US-12037415-B2 | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient | YUYU PHARMA, INC. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20050276810-A1 | Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody | SALAMA ZOSER B | 2005-12-15 | — | — | US | disclosed |
| US-20050272132-A1 | Production of polyketides and other natural products | BIOTICA TECHNOLOGY LIMITED (GB) | 2005-12-08 | — | — | US | disclosed |
| EP-1589031-A2 | Production of polyketides and other natural products | Biotica Technology Limited (GB) | 2005-10-26 | — | — | EP | disclosed |
| US-20040248931-A1 | Isoquinoline compound and pharmaceutical use thereof | MITSUBISHI PHARMA CORPORATION (JP) | 2004-12-09 | — | — | US | disclosed |